Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples